Lanean...

Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting

BACKGROUND: Omalizumab is a monoclonal antibody, indicated for the treatment of severe allergic asthma. In Europe, there have been concerns about the cardiovascular safety of omalizumab. The objective of this study was to analyze the association between omalizumab and arterial thrombotic events in a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ali, Ayad K, Hartzema, Abraham G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2012
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3363016/
https://ncbi.nlm.nih.gov/pubmed/22690127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S29811
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!